Regulatory Novo Nordisk comeback stirs as Wegovy pill wins UK approval Pharmaceutical TechnologyThere are already lengthy patient waitlists for the medication on digital health platforms.Metabolic & GLP-1Read full story pharminent June 12, 2026 (Last updated: June 12, 2026) Pharmaceutical Technology There are already lengthy patient waitlists for the medication on digital health platforms. Metabolic & GLP-1 Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: China’s NMPA approves Akeso’s gumokimab for plaque psoriasisNext: Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win Related Stories Regulatory Novartis receives European Commission approval for Itvisma for spinal muscular atrophy pharminent July 2, 2026 Regulatory Eli Lilly and Regeneron among 7 companies picked for FDA PreCheck pilot program pharminent July 1, 2026 Regulatory Sarepta secures early 2027 FDA decision for Duchenne drugs, pushing past confirmatory fail pharminent July 1, 2026
